Cybrdi, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · CA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|
| Revenue | $574,261 | $783,175 | $546,258 | $819,733 |
| Operating income | −$542,325 | −$431,750 | −$730,020 | −$873,254 |
| Net income | −$548,366 | −$529,800 | −$599,761 | −$750,740 |
| Total assets | $10.4M | $10.6M | $10.9M | $10.2M |
| Total liabilities | $6.4M | $6.1M | $5.8M | $5.2M |
| Equity | $3.0M | $3.4M | $3.9M | $3.7M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 120.2M | 120.2M | 65.8M | 65.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- −94.4%
- Net margin
- −95.5%
- Return on equity
- −18.6%
- Return on assets
- −5.3%
- Return on capital (ROCE)
- −12.4%
- Liabilities / assets
- 61.5%
- Debt / equity
- 2.15×
- Book value / share
- $0.02
- Revenue growth (YoY)
- −26.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Altman Z″ (distress)
- -3.52distress
- Accruals / assets
- 5.7%moderate
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 0 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 17, 2014
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2014
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2014
- NT 10-Kmissed a reporting deadline ↗Apr 2, 2012
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2011
- NT 10-Qmissed a reporting deadline ↗May 17, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Changed auditorFeb 8, 2019
- Entered a material agreementFeb 8, 2019
- Director / officer changeAug 25, 2011
- Director / officer changeJun 5, 2009
- Changed auditor · Regulation FD disclosureMay 6, 2009
- Changed auditorMar 6, 2006
- Changed auditorJun 2, 2005
- Changed auditorApr 29, 2005
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDApr 3, 2020
- 8-K/AFORM 8-K/AFeb 11, 2019
- 8-KFORM 8-KFeb 8, 2019
- 8-KFORM 8-KFeb 8, 2019
- 10-QFORM 10-QNov 19, 2014
- NT 10-QFORM NT 10-QNov 17, 2014
- 10-QFORM 10-QAug 19, 2014
- NT 10-QFORM NT 10-QAug 15, 2014
- 10-QFORM 10-QMay 15, 2014
- 10-KFORM 10-KApr 15, 2014
- NT 10-KFORM NT 10-KApr 1, 2014
- 10-QFORM 10-QNov 14, 2013
- 10-QFORM 10-QAug 14, 2013
- 10-QFORM 10-QMay 15, 2013
- 10-KFORM 10-KApr 1, 2013